Skip to main content
logo
LENSAR, Inc. (LNSR)
NASDAQ: LNSR · Real-Time Price · USD
9.85
-1.83 (-15.67%)
At close: Mar 13, 2026, 4:00 PM EDT
9.91
+0.06 (0.61%)
After-hours: Mar 13, 2026, 4:10 PM EDT

LENSAR Revenue

LENSAR had revenue of $14.32M in the quarter ending September 30, 2025, with 5.74% growth. This brings the company's revenue in the last twelve months to $59.14M, up 21.02% year-over-year. In the year 2024, LENSAR had annual revenue of $53.49M with 26.87% growth.

Revenue (ttm)
$59.14M
Revenue Growth
+21.02%
P/S Ratio
1.99
Revenue / Employee
$422,436
Employees
140
Market Cap
117.65M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202453.49M11.33M26.87%
Dec 31, 202342.16M6.81M19.25%
Dec 31, 202235.36M899.00K2.61%
Dec 31, 202134.46M8.08M30.62%
Dec 31, 202026.38M-4.15M-13.58%
Dec 31, 201930.53M6.14M25.18%
Dec 31, 201824.39M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Treace Medical Concepts212.69M
Xtant Medical Holdings133.08M
Neuronetics129.87M
Owlet105.71M
Apyx Medical52.84M
MaxCyte34.42M
Rapid Micro Biosystems33.59M
Baird Medical Investment Holdings31.86M
Revenue Rankings

LNSR News

More News